Date: September 24-26, 2026
Location: Rosemont, IL, USA
Quanterix is excited to connect with healthcare professionals at Pri-Med Midwest 2026.
Quanterix is proud to participate at the Pri-Med Midwest 2026 Conference, taking place on September 24-26, 2026, at the Donald E. Stephens Convention Center in Rosemont, Illinois. Hosted in partnership with Northwestern University Feinberg School of Medicine, the conference brings together clinicians and healthcare professionals focused on advances in patient care and clinical innovation.
Advancing biomarker detection through ultrasensitive Simoa technology
At Pre-Med Midwest, Quanterix will connect with clinicians and healthcare professionals interested in emerging biomarker technologies and diagnostic innovation. Learn how Simoa technology enables ultra-sensitive protein detection to support research and clinical applications across a wide range of disease areas.
Visit us at booth 713
Conference attendees are invited to connect with the Quanterix team to learn how ultrasensitive biomarker detection is helping advance scientific discovery and clinical research. Visit Booth 713 to discuss emerging applications, current research trends, and opportunities for collaboration.
Meet the Quanterix Team
Connect with Chris Preslin, Senior Business Development Manager
Chris Preslin will be attending Pri-Med Midwest 2026 and looks forward to meeting with healthcare professionals interested in advances in biomarker-based diagnostics and Alzheimer’s disease testing. Stop by Booth 713 to discuss how innovative blood-based testing technologies are helping support clinical decision-making and patient care.
Connect with Chris to set up a meeting
Featured Solution: LucentAD Complete™
LucentAD® Complete is a highly sensitive blood test that measures multiple Alzheimer’s related biomarkers, including p-Tau 217, AB 42/40, GFAP, and NfL. This multi-analyte algorithmic approach reduces the diagnostic uncertainty associated with single biomarker tests, making it an essential tool for Alzheimer’s disease evaluation.
Learn about the HD-X Analyzer
Delivering ultrasensitive biomarker measurement you can count on.
Introducing the world’s most sensitive, fully automated immunoassay platform with multiplexing and custom assay capability.
Up to 1000x greater sensitivity
Up to 4 biomarkers in a single assay
Compatible with 80+ assays
